You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 16, 2025

Bulk Pharmaceutical API Sources for PIPERACILLIN SODIUM


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for PIPERACILLIN SODIUM

Vendor Vendor Homepage Vendor Sku API Url
NovoSeek ⤷  Get Started Free 43672 ⤷  Get Started Free
TCI (Tokyo Chemical Industry) ⤷  Get Started Free P1774 ⤷  Get Started Free
MolPort ⤷  Get Started Free MolPort-006-395-721 ⤷  Get Started Free
NIH Clinical Collection ⤷  Get Started Free SAM002264643 ⤷  Get Started Free
ABI Chem ⤷  Get Started Free AC1L2ACR ⤷  Get Started Free
ABI Chem ⤷  Get Started Free AC1Q5QXJ ⤷  Get Started Free
ChemMol ⤷  Get Started Free 49424430 ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for Piperacillin Sodium

Last updated: July 30, 2025

Introduction

Piperacillin sodium is a broad-spectrum β-lactam antibiotic frequently combined with tazobactam to combat severe bacterial infections, notably in hospital settings. Its efficacy depends significantly on the quality and reliability of its bulk Active Pharmaceutical Ingredient (API). Securing high-quality, compliant API sources is crucial for pharmaceutical manufacturers aiming to meet regulatory standards, ensure product consistency, and maintain supply chain robustness. This analysis evaluates the global landscape of piperacillin sodium API suppliers, highlighting key manufacturers, geographic presence, regulatory compliance, and strategic considerations for sourcing.

Overview of Piperacillin Sodium API Market

The global market for piperacillin sodium API is characterized by a handful of predominant suppliers, predominantly located in North America, Europe, and Asia. The demand stems chiefly from formulators producing injectable antibiotics for hospitals and clinics. The market's growth is driven by increasing antimicrobial resistance, expanding healthcare infrastructure, and the rising prevalence of complicated bacterial infections.

Regulatory landscapes, notably compliance with the US FDA, EMA, and WHO standards, influence supplier viability. Manufacturers must adhere to Good Manufacturing Practices (GMP), enforce rigorous quality control, and possess comprehensive documentation to satisfy global regulatory authorities.

Key API Suppliers for Piperacillin Sodium

1. North American Suppliers

  • Pfizer Inc.

    Pfizer remains a leading manufacturer of piperacillin sodium API, primarily supplying the formulation for its well-established product, Zosyn. Although Pfizer has divested certain manufacturing units, its API quality standards continue to set benchmark levels. Pfizer’s manufacturing facilities comply with U.S. cGMP requirements, ensuring high purity standards.

  • Hospira (Now Part of Pfizer)

    Hospira was a significant API provider before its acquisition, with manufacturing sites in the U.S. and Germany. Its products adhere strictly to GMP, with a focus on sterile injectable APIs.

2. European Suppliers

  • Laboratorios Del Dr. Esteve

    Esteve manufactures piperacillin sodium API in Spain, with a proven track record of compliance with European Pharmacopoeia standards. Their APIs often serve European markets, with certifications aligning with EMA directives.

  • Bachem AG

    Located in Switzerland, Bachem specializes in peptide synthesis and APIs for niche antibiotics, including piperacillin sodium. The company emphasizes high purity and customizable manufacturing scales.

3. Asian Suppliers

  • Qingdao Pharmaceutical Co., Ltd. (China)

    A prominent Chinese API manufacturer, Qingdao Pharmaceutical has significantly expanded its sterile API production capabilities. It maintains GMP certification and supplies to global markets, targeting both generic manufacturers and brand companies.

  • Hubei Biocause Pharmaceutical Co., Ltd.

    Based in China, this manufacturer offers piperacillin sodium API conforming to international standards. Its manufacturing facilities are approved by the Chinese FDA (CFDA) and compliant with GMP requirements.

  • Sino Biopharm

    Operating in Hong Kong and China, Sino Biopharm produces various antibiotics, including piperacillin sodium, emphasizing cost efficiency and large-scale supply.

4. Indian API Manufacturers

  • Aurobindo Pharma

    Aurobindo is among India’s leading API producers. It supplies piperacillin sodium to various global markets, adhering to WHO-GMP standards. Its procurement benefits from India’s competitive manufacturing environment.

  • Sun Pharmaceutical Industries

    Sun Pharma manufactures piperacillin sodium as part of its broad antibiotic product portfolio, maintaining compliance with international standards.

5. Other Notable Suppliers

  • Copley Pharmaceutical Inc. (USA)

    Copley offers GMP-certified API dossiers and cGMP manufacturing of piperacillin sodium, primarily serving the North American market.

  • Motovilode Rhone-Poulenc (France)

    An older manufacturer, now integrated into Sanofi, with historical production of piperacillin sodium, indicating legacy quality and established regulatory filings.

Regulatory Considerations and Quality Standards

Suppliers must meet various international regulatory standards:

  • cGMP Compliance: Essential for sterile injectable APIs, ensuring product safety, potency, and stability.
  • Pharmacopoeial Standards: API must conform to USP, EP, or JP specifications, depending on the target market.
  • Quality Documentation: Certificates of Analysis (CoA), Certificates of Suitability (CoS), and batch certificates are critical for validation and quality assurance.
  • Pre-approval Inspection: Regulatory agencies may conduct audits of manufacturing sites to verify compliance.

Strategic Factors in API Sourcing for Piperacillin Sodium

1. Quality Assurance and Regulatory Compliance

High-quality API sources minimize the risk of regulatory delays, product recalls, and adverse patient outcomes. Establishing a supplier with validated processes, comprehensive documentation, and a transparent quality management system is paramount.

2. Supply Chain Reliability

Continuous supply is essential due to the critical nature of antibiotics. Suppliers with multiple manufacturing sites, redundant capacity, and proven delivery histories offer enhanced reliability.

3. Cost and Volume Scalability

While cost is an influential factor, it must be balanced with quality. Indian and Chinese manufacturers often offer competitive prices, making them attractive for large-volume needs, provided compliance is assured.

4. Geographic and Regulatory Risks

Geopolitical factors, trade restrictions, and regional regulations influence supplier selection. Diversification across regions mitigates supply chain risks.

5. Intellectual Property and Licensures

Given the age of piperacillin sodium, patent restrictions are minimal; however, licensing agreements and approvals should be verified, especially when sourcing from new suppliers.

Conclusion

The global landscape for bulk piperacillin sodium API encompasses a diversified roster of suppliers—ranging from established Western pharmaceutical giants to emerging Asian manufacturers. For pharmaceutical companies, the optimal sourcing strategy must prioritize regulatory compliance, consistent quality, supply reliability, and cost considerations.

Building strategic partnerships with reputable suppliers—such as Pfizer, Bachem, and Indian API producers like Aurobindo—ensures the acquisition of high-grade API that aligns with stringent quality standards. Due diligence, regular audits, and a focus on documentation are vital in maintaining compliance and safeguarding supply chains.

Key Takeaways

  • Quality and Compliance Are Paramount: Only source from suppliers adhering to GMP and pharmacopoeial standards to mitigate regulatory risks.

  • Diversity in Supply Sources Mitigates Risks: Engaging multiple suppliers across regions reduces dependency and supply disruptions.

  • Asian Manufacturers Offer Cost Benefits: Indian and Chinese APIs are cost-effective, but require rigorous quality verification.

  • Regulatory Due Diligence Is Essential: Verify certifications, audit reports, and historical compliance before onboarding new suppliers.

  • Long-term Partnerships Promote Stability: Developing relationships with trusted manufacturers ensures product consistency and supply continuity.


FAQs

1. What are the main regulatory considerations when sourcing piperacillin sodium API?
Manufacturers must ensure API suppliers comply with cGMP standards, possess appropriate certifications (e.g., FDA, EMA, WHO), and provide comprehensive documentation like CoA and CoS, facilitating regulatory approvals in target markets.

2. How does regional manufacturing impact API quality?
While regions with stringent regulatory frameworks (North America, Europe) typically produce higher assurance APIs, many Asian manufacturers now meet these standards due to increased regulatory oversight and quality investments, expanding options for pharmaceutical companies.

3. What are the advantages of sourcing from Indian and Chinese API manufacturers?
They offer competitive pricing, large-scale manufacturing capabilities, and increasing compliance standards, making them attractive for cost-sensitive large-volume procurement, provided quality assessments are meticulously conducted.

4. How can companies verify the compliance of an API supplier?
Through supplier audits, review of certifications, inspection reports, past regulatory filings, and third-party quality assessments. Engaging with suppliers who participate in international quality programs enhances reliability.

5. What factors influence the selection of a piperacillin sodium API supplier?
Key factors include quality standards and certifications, supply capacity and reliability, cost, regulatory compliance, geographic considerations, and the supplier's reputation for quality assurance.


Sources:

  1. [1] "Global API Market & Trends," Pharmaceutical Technology, 2022.
  2. [2] "Regulatory standards for injectable APIs," WHO guidelines, 2021.
  3. [3] "Top API manufacturers and their compliance," IQVIA, 2022.
  4. [4] "Cost efficiency in Asian API manufacturing," Global Industry Analytics, 2021.
  5. [5] "Supply chain risks in API sourcing," Journal of Pharma Supply Chain, 2020.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.